Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01873586 · ClinicalTrials.gov registry record · NA

OsteoStrux™ Collagen Ceramic Scaffold in Instrumented Lumbar Spine Fusion

A NA study of Spondylosis and Stenosis, sponsored by SeaSpine.

Completed
Registry status
NA
Development phase
29
Enrollment target
1
Study location

NCT01873586 is a NA study of Spondylosis and Stenosis that has completed, run by SeaSpine. The registered enrollment target is 29 participants, below the 69-participant average among 8 other Spondylosis trials with a reported enrollment target (58% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01873586, a NA study of Spondylosis and Stenosis, has completed, sponsored by SeaSpine.

COMPLETED
Registry status
NA
Development phase
29 participants
Enrollment target
1
Study location

Study Summary

The objective of this study is to prospectively evaluate the performance of Integra's OsteoStrux Collagen Ceramic Scaffold combined with bone marrow aspirate as an adjunct for instrumented posterolateral spine fusion, as compared to local autograft.

Interventions

  • PROCEDURE Posterolateral Fusion

Study Locations (1)

New York

  • Sherban Orthopaedic and Spine Surgery, PLLC - Kenmore

Trial Details

FieldValue
Enrollment Target 29 participants
Start Date 2012-10
Est. Completion 2016-10
Phase NA

Sponsor

SeaSpine

4 total trials

What the Registry Record Tells You About NCT01873586

The ClinicalTrials.gov registry entry for NCT01873586 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 29 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 69-participant average among 8 other Spondylosis trials with a reported enrollment target (58% lower). The listed sponsor is SeaSpine, which has 4 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Spondylosis appearing as the primary indexed condition, and to 1 intervention - of which Posterolateral Fusion is the first listed.

NCT01873586 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT01873586 about?

NCT01873586 is a clinical study titled "OsteoStrux™ Collagen Ceramic Scaffold in Instrumented Lumbar Spine Fusion". The objective of this study is to prospectively evaluate the performance of Integra's OsteoStrux Collagen Ceramic Scaffold combined with bone marrow aspirate as an adjunct for instrumented posterolateral spine fusion, as compared to local autograft.

What is the current status of trial NCT01873586?

This trial is currently completed. It is a NA study. The enrollment target is 29 participants. The study started on 2012-10. Estimated completion is 2016-10.

What conditions does trial NCT01873586 study?

This clinical trial studies the following conditions: Spondylosis, Stenosis, Degenerative Changes.

What interventions are being tested in trial NCT01873586?

The interventions under investigation include: Posterolateral Fusion (PROCEDURE).

Who is sponsoring clinical trial NCT01873586?

This trial is sponsored by SeaSpine, which has 4 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01873586 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Spondylosis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.